Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:53 am
Author: Getaka|Social: XLinkedIn

FDC Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹328.43Fairly Valued by 0.13%vs CMP ₹328.00

P/E (23.0) × ROE (11.8%) × BV (₹149.00) × DY (1.52%)

₹216.12Overvalued by 34.11%vs CMP ₹328.00
MoS: -51.8% (Negative)Confidence: 63/100 (Moderate)Models: 1 Fair, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹330.9022%Fair (+0.9%)
Graham NumberEarnings₹211.2416%Over (-35.6%)
Earnings PowerEarnings₹132.2713%Over (-59.7%)
DCFCash Flow₹149.7113%Over (-54.4%)
Net Asset ValueAssets₹149.187%Over (-54.5%)
EV/EBITDAEnterprise₹231.299%Over (-29.5%)
Earnings YieldEarnings₹133.107%Over (-59.4%)
ROCE CapitalReturns₹281.389%Over (-14.2%)
Revenue MultipleRevenue₹194.045%Over (-40.8%)
Consensus (9 models)₹216.12100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 0.8%

*Investments are subject to market risks

Investment Snapshot

59
FDC Ltd scores 59/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health72/100 · Strong
ROCE 15.9% GoodROE 11.8% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 69.7% Stable
Earnings Quality60/100 · Moderate
OPM stable around 16% SteadyWorking capital: 33 days (improving) Efficient
Quarterly Momentum40/100 · Moderate
Revenue (4Q): 0% YoY FlatProfit (4Q): -21% YoY Declining
Industry Rank65/100 · Strong
P/E 23.0 vs industry 53.8 Cheaper than peersROCE 15.9% vs industry 16.4% Average3Y sales CAGR: 11% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:53 am

Market Cap 5,345 Cr.
Current Price 328
Intrinsic Value₹216.12
High / Low 528/313
Stock P/E23.0
Book Value 149
Dividend Yield1.52 %
ROCE15.9 %
ROE11.8 %
Face Value 1.00
PEG Ratio30.54

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for FDC Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
FDC Ltd 5,345 Cr. 328 528/31323.0 1491.52 %15.9 %11.8 % 1.00
Entero Healthcare Solutions Ltd 5,424 Cr. 1,247 1,511/94446.6 4060.00 %8.71 %5.63 % 10.0
Aarti Pharmalabs Ltd 5,757 Cr. 635 972/55726.7 2260.79 %17.4 %14.5 % 5.00
Blue Jet Healthcare Ltd 6,089 Cr. 351 1,028/32520.7 72.40.34 %39.8 %30.2 % 2.00
Suven Life Sciences Ltd 3,888 Cr. 147 303/115 12.40.00 %87.0 %87.2 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of FDC Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 409435536486458462638514464492648473465
Expenses 360386414410374406492444417438508439412
Operating Profit 49491227684561477047541403452
OPM % 12%11%23%16%18%12%23%14%10%11%22%7%11%
Other Income 187292725202835191636210
Interest 1111111111111
Depreciation 10101010101011141316151515
Profit before tax 57451419398651639051531603836
Tax % 28%32%22%25%19%29%27%20%28%27%24%26%22%
Net Profit 41311107079461197237391212828
EPS in Rs 2.461.856.624.294.872.847.314.422.282.387.451.741.74

Last Updated: February 6, 2026, 1:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 1:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 8458889941,0131,0741,0891,3411,3311,5251,7841,9432,1082,078
Expenses 6386907657698418601,0389971,2711,5331,6041,7831,798
Operating Profit 207199229243233229304334254251339325280
OPM % 24%22%23%24%22%21%23%25%17%14%17%15%13%
Other Income 394639444542579576501029172
Interest 3211113334455
Depreciation 25393435353337383739405460
Profit before tax 218204232252241237320388289258396357288
Tax % 38%27%27%25%28%28%25%22%25%25%23%25%
Net Profit 135148169189174170240301216194305267217
EPS in Rs 7.618.339.4810.609.959.7414.0317.8512.8211.7018.7516.3913.31
Dividend Payout % 30%27%24%21%0%0%6%0%0%0%0%31%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)9.63%14.19%11.83%-7.94%-2.30%41.18%25.42%-28.24%-10.19%57.22%-12.46%
Change in YoY Net Profit Growth (%)0.00%4.56%-2.35%-19.77%5.64%43.48%-15.76%-53.66%18.05%67.40%-69.68%

FDC Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:9%
3 Years:11%
TTM:4%
Compounded Profit Growth
10 Years:7%
5 Years:2%
3 Years:7%
TTM:-14%
Stock Price CAGR
10 Years:9%
5 Years:8%
3 Years:18%
1 Year:-18%
Return on Equity
10 Years:14%
5 Years:13%
3 Years:12%
Last Year:12%

Last Updated: September 5, 2025, 3:55 am

Balance Sheet

Last Updated: December 10, 2025, 2:39 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 18181818181817171717161616
Reserves 8279191,0651,2521,2591,4281,5301,7171,9401,9652,0812,2652,415
Borrowings 32111115153228212121
Other Liabilities 211210182197228194250207281333350412433
Total Liabilities 1,0591,1481,2661,4681,5051,6401,8131,9562,2702,3432,4682,7142,886
Fixed Assets 284393675678674682674689705699680852842
CWIP 182920613122419105198261137163
Investments 4174893254914715856657908868068431,0281,007
Other Assets 340237246293348360451458575640684698874
Total Assets 1,0591,1481,2661,4681,5051,6401,8131,9562,2702,3432,4682,7142,886

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 150128174154150112250207162155221318
Cash from Investing Activity + -55-89-73-14421-121-98-77-14511-17-199
Cash from Financing Activity + -75-48-970-169-0-142-129-10-180-202-92
Net Cash Flow 19-94111-81017-14226
Free Cash Flow -183-130130114702471483547151227
CFO/OP 105%96%101%92%94%81%110%90%95%93%96%129%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow204.00197.00228.00242.00232.00228.00289.00319.00222.00223.00318.00304.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 262523272829343020252219
Inventory Days 116132134148166184180189210183216186
Days Payable 9094848110182101689499103102
Cash Conversion Cycle 5164729493131113152135109135103
Working Capital Days 11121232945404845485333
ROCE %25%21%22%21%19%17%21%22%15%13%18%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 69.49%69.49%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%
FIIs 3.80%2.06%2.42%2.43%2.65%2.51%2.62%2.67%2.56%2.41%2.43%2.32%
DIIs 8.27%9.13%8.12%7.76%6.94%6.72%6.02%6.08%6.37%7.17%6.81%6.27%
Public 18.44%19.32%19.80%20.15%20.76%21.11%21.71%21.60%21.42%20.76%21.10%21.76%
No. of Shareholders 57,01256,71756,92855,34152,37750,63455,40055,22853,88054,44554,15753,788

Shareholding Pattern Chart

No. of Shareholders

FDC Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund 4,275,331 0.25 161.54,257,2622025-12-08 07:42:130.42%
ICICI Prudential Smallcap Fund 1,987,803 0.92 75.091,930,5872026-02-23 06:32:562.96%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 1,197,689 0.68 45.24N/AN/AN/A
ICICI Prudential ESG Exclusionary Strategy Fund 659,323 1.75 24.91559,3232025-12-14 01:15:3317.88%
Tata India Pharma & HealthCare Fund 645,620 1.97 24.39927,1042026-01-26 03:52:16-30.36%
ICICI Prudential MNC Fund 486,581 1.08 18.38N/AN/AN/A
Bandhan Small Cap Fund 446,288 0.09 16.86N/AN/AN/A
ICICI Prudential Bharat Consumption Fund 214,632 0.26 8.11N/AN/AN/A
ITI Pharma and Healthcare Fund 76,179 1.37 2.8870,9332025-12-15 04:31:047.4%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 16.3918.5811.6612.8117.72
Diluted EPS (Rs.) 16.3918.5811.6612.8117.72
Cash EPS (Rs.) 19.6921.1914.0315.0120.08
Book Value[Excl.RevalReserv]/Share (Rs.) 140.11128.81119.43115.89102.72
Book Value[Incl.RevalReserv]/Share (Rs.) 140.11128.81119.43115.89102.72
Revenue From Operations / Share (Rs.) 129.48119.34107.5190.5178.98
PBDIT / Share (Rs.) 25.5227.0418.1319.5425.54
PBIT / Share (Rs.) 22.2224.5815.7917.3323.30
PBT / Share (Rs.) 21.9424.3415.5417.1422.97
Net Profit / Share (Rs.) 16.3918.7411.6812.8117.84
NP After MI And SOA / Share (Rs.) 16.3918.7511.7012.8217.85
PBDIT Margin (%) 19.7022.6516.8621.5832.33
PBIT Margin (%) 17.1520.6014.6819.1429.49
PBT Margin (%) 16.9420.3914.4518.9429.08
Net Profit Margin (%) 12.6515.7010.8614.1422.59
NP After MI And SOA Margin (%) 12.6515.7010.8714.1622.60
Return on Networth / Equity (%) 11.6914.559.7811.0517.37
Return on Capital Employeed (%) 15.3718.5512.8914.6322.44
Return On Assets (%) 9.8312.368.289.5315.40
Asset Turnover Ratio (%) 0.810.800.770.720.70
Current Ratio (X) 3.013.433.303.674.58
Quick Ratio (X) 1.972.182.242.563.52
Inventory Turnover Ratio (X) 5.521.631.851.751.64
Dividend Payout Ratio (NP) (%) 30.510.000.000.000.00
Dividend Payout Ratio (CP) (%) 25.390.000.000.000.00
Earning Retention Ratio (%) 69.490.000.000.000.00
Cash Earning Retention Ratio (%) 74.610.000.000.000.00
Interest Coverage Ratio (X) 92.13109.1173.60106.74125.53
Interest Coverage Ratio (Post Tax) (X) 60.1676.6248.4270.9789.32
Enterprise Value (Cr.) 6366.946886.084231.474298.404791.75
EV / Net Operating Revenue (X) 3.023.542.372.813.59
EV / EBITDA (X) 15.3215.6414.0713.0311.12
MarketCap / Net Operating Revenue (X) 3.053.562.392.843.62
Retention Ratios (%) 69.480.000.000.000.00
Price / BV (X) 2.813.302.152.222.78
Price / Net Operating Revenue (X) 3.053.562.392.843.62
EarningsYield 0.040.040.040.040.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

FDC Ltd. is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2070.11 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsB-8, MIDC Industrial Estate, Aurangabad District Maharashtra 431136Contact not found
Management
NamePosition Held
CA. Uday Kumar GurkarChairman & Ind.Director
Mr. Mohan A ChandavarkarManaging Director
Mr. Nandan M ChandavarkarJoint Managing Director
Mr. Ameya A ChandavarkarExecutive Director & CEO
Mr. Ashok A ChandavarkarExecutive Director
Ms. Nomita R ChandavarkarNon Exe.Non Ind.Director
Dr. Mahesh BijlaniIndependent Director
Mr. Vijay ManiarIndependent Director
Mr. Vijay Nautamlal BhattIndependent Director
Dr. Charuta Nityanath MandkeIndependent Director

FAQ

What is the intrinsic value of FDC Ltd and is it undervalued?

As of 19 April 2026, FDC Ltd's intrinsic value is ₹216.12, which is 34.11% lower than the current market price of ₹328.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (11.8 %), book value (₹149), dividend yield (1.52 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of FDC Ltd?

FDC Ltd is trading at ₹328.00 as of 19 April 2026, with a FY2026-2027 high of ₹528 and low of ₹313. The stock is currently near its 52-week low. Market cap stands at ₹5,345 Cr..

How does FDC Ltd's P/E ratio compare to its industry?

FDC Ltd has a P/E ratio of 23.0, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is FDC Ltd financially healthy?

Key indicators for FDC Ltd: ROCE of 15.9 % indicates efficient capital utilization. Dividend yield is 1.52 %.

Is FDC Ltd profitable and how is the profit trend?

FDC Ltd reported a net profit of ₹267 Cr in Mar 2025 on revenue of ₹2,108 Cr. Compared to ₹216 Cr in Mar 2022, the net profit shows an improving trend.

Does FDC Ltd pay dividends?

FDC Ltd has a dividend yield of 1.52 % at the current price of ₹328.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in FDC Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports